Da2Pp Vaccine

Verify with FDA CVM →

184 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
184
Total Reports
15
Deaths Reported
820.0%
Death Rate

Active Ingredients

Da2Pp Vaccine

Administration Routes

UnknownParenteralSubcutaneous

Species Affected

Dog 184

Most Affected Breeds

Retriever - Labrador 17
Retriever - Golden 10
Crossbred Canine/dog 8
Shepherd Dog - German 7
Dachshund (unspecified) 6
Terrier - Jack Russell 6
Chihuahua 5
Shih Tzu 5
Pug 5
Maltese 5

Most Reported Reactions

Emesis 57
Vomiting 53
Lethargy (see also Central nervous system depression in 'Neurological') 45
Anorexia 14
Diarrhoea 13
Ataxia 9
Weight loss 8
Death 8
Lack of efficacy - NOS 8
Other abnormal test result NOS 8
Fever 7
Pruritus 7

Outcome Breakdown

Recovered/Normal
113 (61.4%)
Outcome Unknown
31 (16.8%)
Ongoing
13 (7.1%)
Recovered with Sequela
12 (6.5%)
Died
10 (5.4%)
Euthanized
5 (2.7%)

Data Summary

Metric Value
Total adverse event reports 184
Reports involving death 15
Case-fatality rate (reported events) 820.0%
Distinct species in reports 1
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Da2Pp Vaccine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 184 adverse event reports referencing Da2Pp Vaccine, including 15 reports in which the animal died — a 820.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Da2Pp Vaccine. Reported administration routes include Unknown, Parenteral, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Da2Pp Vaccine reports are Dog (184 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (17), Retriever - Golden (10), Crossbred Canine/dog (8) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Da2Pp Vaccine are Emesis (57), Vomiting (53), Lethargy (see also Central nervous system depression in 'Neurological') (45), Anorexia (14). Of the 184 reports with a coded outcome, Recovered/Normal is the leading category at 61.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Da2Pp Vaccine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial